Skip to main content

Construction of lncRNA-related competing endogenous RNA network and identification of hub genes in recurrent implantation failure



The mechanism of recurrent implantation failure (RIF) is unclear at present and poor endometrial receptivity may be one of the leading reasons. This study aims to construct a competing endogenous RNA (ceRNA) network and identify potential hub genes underlying the development of RIF.


Weighted gene co-expression network analysis was performed based on differentially expressed mRNAs (DEMs) and lncRNAs (DELs) from the GSE111974 dataset. Functional enrichment analyses of gene modules were conducted using Gene Ontology classification and Kyoto Encyclopedia of Genes and Genomes pathway. A lncRNA-miRNA-mRNA ceRNA regulatory network was constructed according to predictive interaction derived from the LncRNADisease, miRTarBase, miRDB and TargetScan databases. Topological analysis determined the key genes with the highest centroid and their expressions were further verified using public datasets and quantitative real-time polymerase chain reaction.


A total of 1500 DEMs and 3 DELs were significantly up-regulated, whereas 1022 DEMs and 4 DELs were significantly down-regulated in the RIF group compared with the control group. Six functional co-expression modules were enriched in various biological processes, such as cell adhesion, regulation of cell motility and cellular response to vascular endothelial growth factor stimulus. Five hub genes were identified in the ceRNA network, of which GJA1 was down-regulated whereas TET2, MAP2K6, LRRC1 and TRPM6 were up-regulated in RIF endometrium.


We constructed a lncRNA-associated ceRNA network and identified five novel hub genes in RIF. This finding could be helpful to understand the molecular mechanism for RIF pathogenesis, and may provide novel insights for its early diagnosis and treatment.


Successful implantation is a process which requires a synchronized and coordinated interaction between the embryo and the endometrium [1]. Over the past decades, in vitro fertilization-embryo transfer (IVF-ET) has become an effective approach for infertility treatment with the improvements in ovarian stimulation and laboratory procedures [2]. Nevertheless, for each IVF-ET cycle, the rates of implantation and livebirth still remain modest at best [3]. In addition, a significant proportion of couples would experience recurrent implantation failure (RIF), leading to great financial and psychological burden in these patients [4].

The definition of RIF is varied and no consensus has been reached yet [5]. According to the latest criteria proposed by Coughlan et al. [6], RIF refers to the failure to achieve clinical pregnancy after transfer of ≥ 4 morphologically good-quality embryos for ≥ 3 fresh or frozen-thawed cycles in women less than 40 years old. Recent evidences suggest that RIF may be mainly associated with poor endometrial receptivity and several molecular changes have been detected in women with RIF, such as mucin 1, integrin β3, homeobox A10 and leukemia inhibitor factor [5, 7,8,9,10]. However, the precise etiology and pathogenesis of RIF have not been fully revealed. Further studies are still urgently needed to elucidate the underlying mechanism, identify new prognostic biomarkers and develop potential therapeutic targets.

With the advances in high-throughput sequencing technology, it is now well-established that the regulation of biological processes not only relies on protein-coding messenger RNA (mRNA), but also on non-coding RNA such as micro RNA (miRNA), circular RNA and long non-coding RNA (lncRNA) [11]. LncRNA, located in the cell nucleus and/or cytoplasm, is > 200 nucleotides in transcript length [12]. By competing for and binding to shared miRNAs, lncRNAs can regulate the expression of other mRNAs, which is called competing endogenous RNA (ceRNA) network [12]. At present, the ceRNA network has been proven to be involved in the development of various diseases, including cancer [13], gestational diabetes [14], systemic lupus erythematosus [15] and polycystic ovary syndrome [16]. Moreover, accumulating studies show that specific mRNAs, miRNAs and lncRNAs are differentially expressed in the secretory endometrium of RIF women, indicating their involvement in endometrial receptivity defects [17,18,19,20,21]. Nonetheless, the regulatory mechanism of the lncRNA-miRNA-mRNA ceRNA network in RIF is still poorly investigated and remains largely unclear so far [22, 23].

In the present study, we obtained RIF-related expression profiles of mRNAs and lncRNAs from the Gene Expression Omnibus (GEO) database. The co-expression modules and ceRNA network were constructed following integrated bioinformatic analyses, with novel hub genes identified and validated as potential targets for the pathogenesis of RIF.


Data collection and pre-processing

Series matrix files of three datasets (GSE111974, GSE71835 and GSE103465) were downloaded from the GEO database ( The platforms were based on GPL17077 (Agilent-039494 SurePrint G3 Human GE v2 8 × 60 K Microarray 039381), GPL10558 (Illumina HumanHT-12 V4.0 expression bead chip) and GPL15207 (GeneChip® PrimeView™ Human Gene Expression Array), respectively. All data were processed by the R software (version 3.4.0; and normalized by Robust Multichip Average (RMA) algorithms. GSE111974 was used to screen the key genes related to RIF [24], whereas GSE71835 and GSE103465 were utilized for verification [25, 26].

Identification of differentially expressed mRNAs (DEMs) and lncRNAs (DELs)

The limma package was used for identifying DEMs and DELs between the RIF samples and matched normal samples in GSE111974 [27]. An adjusted P < 0.05 and an absolute log2 fold change (|log2FC|) > 1 were considered statistically significant. According to the similarity of lncRNAs and mRNAs expression level, two-way hierarchical clustering and heatmap illustration were performed by the heatmap package in R software to classify samples into different groups and reveal the relationship between different samples.

Construction of co-expression network

Gene co-expression networks were constructed based on DEMs and DELs using the weighted gene co-expression network analysis (WGCNA) package in R software [28]. Firstly, the outliers in the samples with limited expression information were checked and removed. Subsequently, the power of β-value was introduced to transform the similarity matrix into an adjacency matrix. For the best scale-free fit index and average connectivity, the soft thresholding value (β) was determined to be 14 in the present study. On this basis, the topological overlap matrix (TOM) and the corresponding dissimilarity values (1-TOM) were further calculated [29]. Ultimately, genes with highly absolute correlations were clustered into the same module to generate a cluster dendrogram by The Dynamic Tree Cut method. The minimum number of genes per module was pre-set to be 10.

Functional enrichment analysis

To further analyze the potential biological processes, cellular components, molecular functions and pathways of the gene modules, the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID, [30]. GO terms and KEGG pathways were classified as enriched when P < 0.05.

Construction of ceRNA network

To construct the ceRNA network, we obtained the predictive interaction of DELs in the WGCNA modules with miRNAs from the LncRNADisease database ( [31]. Meanwhile, the interaction between DEMs and miRNAs were downloaded and validated using the following three databases: miRTarBase ( [32], miRDB ( [33] and TargetScan ( [34]. A lncRNA-miRNA‐mRNA ceRNA network was constructed and visualized based on lncRNA‐miRNA and miRNA‐mRNA pairs using the Cytoscape software (version 3.7.0; Cytoscape Consortium, USA).

Identification of hub genes

The mRNAs in the intersection of the WGCNA network and the ceRNA network were considered to play key roles. These mRNAs were re-mapped into the WGCNA network and we then assessed the topological property of each node in the interaction network by calculating three parameters: degree centrality (DC), betweenness centrality (BC) and closeness centrality (CC). Generally, a larger quantitative value indicates a greater significance of the node in the network. The MATLAB Z-score function was used to standardize these parameters and the formula was as follows: Z-score = (x–mean(x))/std(x), where x was the value of the topological parameter, mean (x) denoted the mean value and std (x) represented the standard deviation [35]. After summing the DC, BC and CC Z-scores of each node, we selected the top 5 genes as the hub genes in the network.

Validation of hub lncRNAs and genes

To verify the differential expression of hub lncRNAs and genes in RIF patients, expression data were further extracted from the GSE71835 and GSE103465 datasets. The Wilcoxon test was performed for between-group comparison. The level of statistical significance was set at P < 0.05 on two-sided test.

Sample collection

Endometrial tissues were obtained from patients who underwent IVF-ET treatment at the Reproductive Medical Center, the First Affiliated Hospital of Wenzhou Medical University. Specifically, pipe suction curettage (Runting, Soochow, China) was used to collect mid-secretory endometrium in 7 days after ovulation during natural menstrual cycles. The RIF group consisted of 10 women that failed to conceive after 3 or more transfer cycles with at least 4 morphologically high-grade embryos [6]. The control group included another 10 women that achieved clinical pregnancy in their first or second embryo transfer. All women were less than 40 years old, exhibited regular ovulation and normal body mass index, and had no hormonal therapy in the last 3 months. Exclusion criteria were as follows: congenital uterine malformations, uterine fibroids, endometrial polyps or hyperplasia, intrauterine adhesions, endometritis, endometriosis, adenomyosis, hydrosalpinx, polycystic ovary syndrome, hyperprolactinemia, thyroid dysfunction, thrombotic disorders, immune-related diseases, infectious diseases and abnormal parental karyotypes. All participants provided written informed consents and ethical approval was obtained from the Institutional Review Board of the First Affiliated Hospital of Wenzhou Medical University (No. 2019-07).

RNA extraction and quantitative real-time polymerase chain reaction (qRT-PCR)

Total RNA was extracted from endometrial samples by TRIzol™ Reagent (Invitrogen, Carlsbad, USA) and reverse-transcribed into cDNA using PrimeScript™ RT Master Mix (TaKaRa, Dalian, China). The qRT-PCR was conducted in triplicates using TB Green™ Premix Ex Taq™ II (TaKaRa, Dalian, China) on the QuantStudio™ 6 Flex Real-Time PCR System (Applied Biosystems, Foster City, USA). Relative mRNA expression was analyzed by the 2Ct method and normalized to β-actin as the endogenous reference gene. The primer sequences of targeted genes are presented in Table S1.

Statistical analysis

Quantitative variables were presented as mean ± standard deviation. After assessment of normality by the Shapiro-Wilk test, comparisons between the control and RIF groups were performed using the Student’s t test (for parametric data) or Mann-Whitney U test (for nonparametric data). For qualitative variables, data were described as number with proportion, and compared by χ2 test or Fisher’s exact test as appropriate. Differences were considered to be statistically significant for P < 0.05. All statistical analyses were conducted in SPSS 26.0 software (IBM Corp., Armonk, USA).


Data acquisition

From the GSE111974 dataset, we downloaded expression profiles in the endometrial tissue samples of 24 patients with RIF and 24 normal women of childbearing age by RNA-sequencing. A total of 17,596 genes were obtained for analysis, including 17,154 mRNAs and 442 lncRNAs. In addition, the GSE71835 dataset included expression profiles of 6 RIF and 6 normal women, and the GSE103465 dataset had 3 samples in each respective group.

Identification of DEMs and DELs

A total of 2522 DEMs and 7 DELs were identified from the GSE111974 dataset. Among them, 1500 DEMs and 3 DELs were significantly up-regulated, whereas 1022 DEMs and 4 DELs were significantly down-regulated in the RIF group compared with those in the normal group. The corresponding volcano plot and clustering heatmaps are shown in Fig. 1.

Fig. 1
figure 1

Identification of DEMs and DELs based on GSE111974 dataset. A Volcano plot of differentially expressed genes in endometria of RIF and control groups. The red dots represent significantly upregulated genes, and the green dots represent significantly downregulated genes. Hierarchical clustering heatmaps of (B) DELs and (C) DEMs in endometria of RIF and control groups. The color from green to red shows a trend from low expression to high expression. DEMs, differentially expressed mRNAs; DELs, differentially expressed lncRNAs; RIF, recurrent implantation failure

Construction of co-expression network

We identified seven co-expression modules using WGCNA, which revealed the molecular gene regulatory networks based on pairwise correlations between the differentially expressed RIF RNAs (Fig. 2). The RNAs that might function together were considered as one module and assigned with one color. The gray represented all genes that could not be incorporated into any module. As the remaining module network presented, the blue module included 63 mRNAs and 2 lncRNAs; the green module included 31 mRNAs; the brown module included 66 mRNAs and 1 lncRNA; the red module included 10 mRNAs and 3 lncRNAs; the yellow module included 44 mRNAs; and the turquoise module included 203 mRNAs and 1 lncRNA (Fig. 3).

Fig. 2
figure 2

Weighted gene co-expression network analysis based on GSE111974 dataset. A Sample clustering to detect outliers. B Scale-free topology model fit (left) and mean connectivity (right) for determining the optimal soft threshold value. C Cluster dendrogram of genes. Each branch represents one gene and seven modules are displayed in different colors

Fig. 3
figure 3

Co-expression networks of the six modules. A The blue module. B The brown module. C The green module. D The red module. E The turquoise module. F The yellow module. The round nodes represent mRNAs, the triangle nodes represent lncRNAs, and the edges between nodes indicate co-expressions

Functional enrichment analysis

To explore the functional roles of these different modules, the GO and KEGG analyses were further performed. The results showed that various biological processes may be involved in the pathogenesis of RIF, such as cell adhesion, regulation of cell motility, regulation of cell proliferation, activation of mitogen-activated protein kinase (MAPK) activity and cellular response to vascular endothelial growth factor (VEGF) stimulus (Fig. 4). The number of genes in the red module was too small to get functional enrichment results.

Fig. 4
figure 4

GO and KEGG enrichment analyses of the five modules. A The blue module. B The brown module. C The turquoise module. D The yellow module. E The green module. The X-axis represents enriched terms, the left Y-axis represents the number of enriched genes, and the right Y-axis represents the P-value. GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; BP, biological process; CC, cellular component; MF, molecular function

Construction of ceRNA network

Based on the WGCNA co-expression modules, the interactions between lncRNAs/mRNAs and miRNAs were further predicted and a lncRNA-miRNA-mRNA ceRNA network was constructed (Fig. 5). Seven lncRNAs with the highest degree were selected as hub lncRNAs, including C1orf229, H19, PART1, SCARNA9, SNHG11, LINC00173 and MIR17HG (Fig. 6). The predicted lncRNA-miRNA and mRNA-miRNA pairs for WGCNA modules and hub lncRNA-related ceRNA networks are detailed in Tables S2 and  S3, respectively.

Fig. 5
figure 5

Construction of the competing endogenous RNA network. The red nodes represent lncRNAs, the green nodes represent miRNAs, and the blue nodes represent mRNAs. Only the nodes in the top 200 of degree ranking are presented

Fig. 6
figure 6

Competing endogenous RNA networks of seven hub lncRNAs. A C1orf229. B H19. C PART1. D SCARNA9. E SNHG11. F LINC00173. G MIR17HG. Nodes with different colors and shapes represent different RNA types

Validation of hub lncRNAs

Figure S1 presents specifically the expression patterns of seven hub lncRNAs, which were further validated in another public dataset GSE71835. Consistently, the expression levels of PART1 and MIR17HG were significantly increased in RIF endometrium (Figure S2C and G), while those of H19 and LINC00173 were significantly decreased (Figure S2B and F). C1orf229, SCARNA9 and SNHG11 were also differentially expressed between RIF patients and controls, but the changes were not statistically significant (P > 0.05) (Figure S2A, D and E).

Identification and validation of hub genes

To identify the RIF-related hub genes, we re-mapped the significantly DEMs in the ceRNA network to the WGCNA co-expression network. The final network consisted 23 nodes and 51 edges (Fig. 7). After sorting by the sum of Z-scores, a total of five genes were identified as hub genes, including TET2, GJA1, MAP2K6, LRRC1 and TRPM6. The details are presented in Table S4.

Fig. 7
figure 7

Co-expression network of overlapped genes in WGCNA and ceRNA analyses. The blue nodes represent mRNAs and the edges between nodes indicate co-expressions. WGCNA, weighted gene co-expression network analysis; ceRNA, competing endogenous RNA

According to the expression profile analysis of the GSE111974 dataset, TET2, MAP2K6, LRRC1 and TRPM6 showed significantly higher expression while GJA1 showed significantly lower expression in the RIF group compared with the control group (P < 0.05) (Fig. 8). Consistently, in the GSE71835 dataset, the expression of LRRC1, MAP2K6 and TRPM6 were also significantly higher in the endometrium of RIF patients (P < 0.05) (Fig. 9B, C and E), while data on GJA1 and TET2 could not be obtained. On the other hand, we found a trend for higher TET2 and lower GJA1 expression in the RIF group in the GSE103465 dataset, although no statistical differences were reached possibly due to the small sample size (both P = 0.1) (Fig. 9A and D). In general, the expression analyses of five hub genes in the external validation datasets were accordant with the results from the discovery dataset.

Fig. 8
figure 8

Differential expression of five hub genes in GSE111974 dataset. A GJA1. B LRRC1. C MAP2K6. D TET2. E TRPM6. RIF, recurrent implantation failure

Fig. 9
figure 9

Differential expression of five hub genes in validation datasets GSE71835 and GSE103465. A GJA1. B LRRC1. MAP2K6. D TET2. E TRPM6. RIF, recurrent implantation failure

The identified candidate genes were further assayed by qRT-PCR on a sample set of 10 RIF patients and 10 controls. Except for the number of embryo transfers (P < 0.001), other demographic characteristics were comparable between the two groups (all P > 0.05) (Table S5). As shown in Fig. 10, the mRNA expressions of GJA1, MAP2K6, LRRC1 and TRPM6 displayed the same trend as our in silico results, while no significant difference was detected in TET2.

Fig. 10
figure 10

Validation of hub genes in the endometrium of RIF patients and controls by qRT-PCR. RIF, recurrent implantation failure. ns, not significant. * P < 0.05


As a complicated and poorly understood clinical disorder in IVF-ET cycles, RIF has brought significant burden to patients and therapeutic challenges to physicians. In this study, we applied an integrated bioinformatic approach to establish the RIF-related co-expression network and ceRNA network. In addition, five novel hub genes were identified and further validated as potential molecular targets underlying the development of RIF.

Six functional modules associated with RIF were built by WGCNA and analyzed in depth. In general, the GO and KEGG analyses showed that enriched genes and pathways were mainly involved in basic and essential biological events, such as cell adhesion, regulation of cell motility and regulation of cell proliferation, which were consistent with previous researches [17,18,19,20,21]. Indeed, in preparation for embryo implantation, the endometrial luminal epithelium must convert to an adhesive state for subsequent invasion of the hatched blastocyst [36]. Penetration of the trophoblasts also triggers a series of endometrial response called decidualization, which involves massive proliferation and differentiation of the stromal cells [37]. Moreover, activation of MAPK activity was found to be enriched in the turquoise module, which has been demonstrated to promote the proliferation of endometrial cells, the enhancement of uterine capacity and the maintenance of pregnancy [38, 39]. As one of the most important angiogenic factors, VEGF plays a vital role in decidual vascularization and placenta angiogenesis. Prior studies also suggest that VEGF polymorphisms are closely associated with the development of RIF [40, 41]. Accordingly, we found a significant enrichment of cellular response to VEGF stimulus in the brown module.

In the present study, seven hub lncRNAs with the highest degree were identified and verified in the ceRNA network, including C1orf229, H19, PART1, SCARNA9, SNHG11, LINC00173 and MIR17HG. Among them, the lncRNA H19, which is mainly located in the cytoplasm with a length of approximately 2.3 kb, plays diverse roles in multiple physiological and pathological processes [11, 12]. In human endometrium, H19 is confined to the endometrial stroma and expressed in a menstrual cycle-dependent manner, with peaks reached during the late proliferative stage [42]. Previous studies have shown that the expression of H19 was significantly decreased in women with unexplained infertility [43], spontaneous abortion [44], endometriosis [45] as well as RIF [46]. Acting as a molecular sponge, H19 downregulation could increase the activity of miRNA let-7 and thus inhibit its downstream target ITGB3 at the post‐transcriptional level, which further contributes to impaired adhesion and invasiveness of extravillous trophoblast [47]. In addition, aberration of the H19/let‐7/IGF1R regulatory pathway has been associated with a negative impact on stromal cell proliferation and may thus decrease endometrial receptivity for pregnancy [45]. Overexpression of PART1, SNHG11, LINC00173 and MIR17HG is widely involved in tumorigenesis and malignant progression of several types of cancer, such as glioma, breast cancer, lung cancer and colorectal cancer [48,49,50,51,52]. Potential mechanisms have been focused on the promotion of cell proliferation, migration, invasion and epithelial-mesenchymal transition, which are also important for the establishment of receptive endometria and the process of embryo implantation [36, 37]. Therefore, these lncRNAs may regulate the development of RIF as well, although no relevant findings have been reported for confirmation thus far. With regard to molecular mechanisms of C1orf229 and SCARNA9, the scarce studies at present require the need for further investigations.

Co-analysis of the WGCNA network and the lncRNA-related ceRNA network identified five novel hub genes in RIF, namely TET2, GJA1, MAP2K6, LRRC1 and TRPM6. The differential expression was also in general consistency among the discovery dataset GSE111974, the validation datasets GSE71835/GSE103465 and qRT-PCR analysis using in vivo samples. Dysregulation of TET2 is commonly observed in myeloid and lymphoid malignancies [53]. As one of the three proteins in the TET (ten-eleven translocation) family, TET2 is an α-ketoglutarate-dependent dioxygenase that enables the conversion of 5-methyl-cytosine to 5-hydroxymethyl-cytosine and promotes DNA demethylation [54]. In this regard, the increased TET2 in RIF might be associated with hypomethylation of CYP19A1, ESR2 and SF-1 genes, thus leading to an estradiol-rich endometrial environment and defective decidualization [55,56,57]. Connexin 43 (Cx43), the product of GJA1 gene, is a constitutive part of gap junction intercellular communication and predominantly expressed in endometrial stroma [58]. Ablation of Cx43 expression has been reported to suppress proliferation, impair differentiation and induce apoptosis of endometrial stromal cells [58, 59]. The production of key angiogenic factors (e.g., VEGF) was also significantly reduced, whereas the secretion of inflammatory mediators was increased [60]. Collectively, there disruptions could result in an unreceptive endometrium with embryo growth arrest and early pregnancy loss [58]. MAP2K6 is an upstream kinase of the p38 MAPK signal cascade activated under the status of inflammation and stress. Previous studies have demonstrated that MAP2K6 plays crucial roles in various biological processes, such as cell cycle regulation, transcription and apoptosis [61]. In Ishikawa endometrial cell lines, transfection of MAP2K6 could stimulate the estrogen-mediated transcription and proliferation through selective activation of p38 MAPK, which further phosphorylates and potentiates the p160 coactivator glucocorticoid receptor-interacting protein 1 [62]. Therefore, MAP2K6 upregulation in RIF may augment estrogen action in the secretory endometrium and thus impair the progesterone-dependent decidualization process. LRRC1 belongs to the LAP protein family and is vital for the establishment and maintenance of apical-basal cell polarity. Throughout the proliferative phase of the menstrual cycle, human endometrial luminal epithelium also displays a distinct polarized organization. However, during the secretory phase, loss of polarity must occur to overcome mutual repulsion and thus facilitate the interaction with embryos for implantation [63, 64]. In this regard, high LRRC1 expression may impede cellular rearrangements for polarity modulation and consequently lead to the development of RIF. As the member of TRP (transient receptor potential) superfamily, TRPM6 acts as an important ion channel for Ca2+/Mg2+ influx that transduces environmental stimuli into cellular responses [65]. In human endometrium, the expression of TRPM6 increases during the follicular phase, peaks in the early luteal phase, but decreases sharply in the late luteal phase when progesterone levels are high [66, 67]. This specific downregulation around the window of implantation suggests that TRPM6 might be important to necessitate functional progesterone receptors and confer endometrial receptivity. Contrarily, significant upregulation of TRPM6 was found in women with RIF, further implicating its possible role in mediating decidualization and embryo implantation. Overall, these hub genes provide novel insights into the pathogenesis of RIF and deserve more exploration on the detailed mechanisms.

Some limitations should be acknowledged of the current study. On the one hand, the sample size of our analyzed dataset was relatively small, with only 24 RIF patients and 24 control women enrolled. Therefore, the results may not be robust enough and more studies with larger sample size should be carried out in the future. On the other hand, although the expression of hub genes was validated in endometrial tissue samples from IVF-ET patients, we did not assess further their biological functions predicted by bioinformatic tools. In this regard, we have obtained the hospital’s ethical approval for study and several in vitro experiments are now undergoing for more investigation.


In summary, our study provided a comprehensive bioinformatic analysis of the WGCNA co-expression network and lncRNA-associated ceRNA network for RIF. We identified five novel hub genes that showed significantly differential expression in RIF and may play crucial roles in endometrial receptivity. Our findings could be helpful to further understand the molecular mechanisms for RIF pathogenesis, and also lay a foundation for the discovery of potential diagnostic and therapeutic targets.

Availability of data and materials

The datasets supporting the conclusions of this article are included within the article and its additional files.



Betweenness centrality


Closeness centrality


Competing endogenous RNA


:Connexin 43


Database for Annotation, Visualization and Integrated Discovery


Degree centrality


Differentially expressed long non-coding RNAs


Differentially expressed messenger RNAs


Gene Expression Omnibus


Gene Ontology


In vitro fertilization-embryo transfer


Kyoto Encyclopedia of Genes and Genomes


Long non-coding RNA


Messenger RNA


Mitogen-activated protein kinase


Micro RNA


Quantitative real-time polymerase chain reaction


Recurrent implantation failure


Ten-eleven translocation


Topological overlap matrix


Vascular endothelial growth factor


Weighted gene co-expression network analysis


  1. Diedrich K, Fauser BC, Devroey P, Griesinger G. The role of the endometrium and embryo in human implantation. Hum Reprod Update. 2007;13:365–77.

    Article  CAS  PubMed  Google Scholar 

  2. Kushnir VA, Barad DH, Albertini DF, Darmon SK, Gleicher N. Systematic review of worldwide trends in assisted reproductive technology 2004–2013. Reprod Biol Endocrinol. 2017;15:6.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Adamson GD, de Mouzon J, Chambers GM, Zegers-Hochschild F, Mansour R, Ishihara O, et al. International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2011. Fertil Steril. 2018;110:1067–80.

    Article  PubMed  Google Scholar 

  4. Bashiri A, Halper KI, Orvieto R. Recurrent Implantation Failure-update overview on etiology, diagnosis, treatment and future directions. Reprod Biol Endocrinol. 2018;16:121.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Timeva T, Shterev A, Kyurkchiev S. Recurrent implantation failure: the role of the endometrium. J Reprod Infertil. 2014;15:173–83.

    PubMed  PubMed Central  Google Scholar 

  6. Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, et al. Recurrent implantation failure: definition and management. Reprod Biomed Online. 2014;28:14–38.

    Article  CAS  PubMed  Google Scholar 

  7. Bellver J, Simón C. Implantation failure of endometrial origin: what is new? Curr Opin Obstet Gynecol. 2018;30:229–36.

    Article  PubMed  Google Scholar 

  8. Wu F, Chen X, Liu Y, Liang B, Xu H, Li TC, et al. Decreased MUC1 in endometrium is an independent receptivity marker in recurrent implantation failure during implantation window. Reprod Biol Endocrinol. 2018;16:60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Yang Y, Chen X, Saravelos SH, Liu Y, Huang J, Zhang J, et al. HOXA-10 and E-cadherin expression in the endometrium of women with recurrent implantation failure and recurrent miscarriage. Fertil Steril. 2017;107:136–43 e2.

    Article  CAS  PubMed  Google Scholar 

  10. Choi Y, Kim HR, Lim EJ, Park M, Yoon JA, Kim YS, et al. Integrative Analyses of Uterine Transcriptome and MicroRNAome Reveal Compromised LIF-STAT3 Signaling and Progesterone Response in the Endometrium of Patients with Recurrent/Repeated Implantation Failure (RIF). PLoS One. 2016;11:e0157696.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Hombach S, Kretz M. Non-coding RNAs: Classification, Biology and Functioning. Adv Exp Med Biol. 2016;937:3–17.

    Article  CAS  PubMed  Google Scholar 

  12. Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17:47–62.

    Article  CAS  PubMed  Google Scholar 

  13. Qi X, Zhang DH, Wu N, Xiao JH, Wang X, Ma W. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52:710–8.

    Article  PubMed  CAS  Google Scholar 

  14. Leng L, Zhang C, Ren L, Li Q. Construction of a long non–coding RNA-mediated competitive endogenous RNA network reveals global patterns and regulatory markers in gestational diabetes. Int J Mol Med. 2019;43:927–35.

    CAS  PubMed  Google Scholar 

  15. Li LJ, Zhao W, Tao SS, Leng RX, Fan YG, Pan HF, et al. Competitive endogenous RNA network: potential implication for systemic lupus erythematosus. Expert Opin Ther Targets. 2017;21:639–48.

    Article  CAS  PubMed  Google Scholar 

  16. Wang W, Ji J, Li J, Ren Q, Gu J, Zhao Y, et al. Several critical genes and microRNAs associated with the development of polycystic ovary syndrome. Ann Endocrinol (Paris). 2020;81:18–27.

    Article  Google Scholar 

  17. Koot YE, van Hooff SR, Boomsma CM, van Leenen D, Groot Koerkamp MJ, Goddijn M, et al. An endometrial gene expression signature accurately predicts recurrent implantation failure after IVF. Sci Rep. 2016;6:19411.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Huang J, Qin H, Yang Y, Chen X, Zhang J, Laird S, et al. A comparison of transcriptomic profiles in endometrium during window of implantation between women with unexplained recurrent implantation failure and recurrent miscarriage. Reproduction. 2017;153:749–58.

    Article  CAS  PubMed  Google Scholar 

  19. Shi C, Shen H, Fan LJ, Guan J, Zheng XB, Chen X, et al. Endometrial MicroRNA Signature during the Window of Implantation Changed in Patients with Repeated Implantation Failure. Chin Med J (Engl). 2017;130:566–73.

    Article  CAS  Google Scholar 

  20. Fan LJ, Han HJ, Guan J, Zhang XW, Cui QH, Shen H, et al. Aberrantly expressed long noncoding RNAs in recurrent implantation failure: A microarray related study. Syst Biol Reprod Med. 2017;63:269–78.

    Article  CAS  PubMed  Google Scholar 

  21. Chen MY, Liao GD, Zhou B, Kang LN, He YM, Li SW. Genome-Wide Profiling of Long Noncoding RNA Expression Patterns in Women With Repeated Implantation Failure by RNA Sequencing. Reprod Sci. 2019;26:18–25.

    Article  CAS  PubMed  Google Scholar 

  22. Feng C, Shen JM, Lv PP, Jin M, Wang LQ, Rao JP, et al. Construction of implantation failure related lncRNA-mRNA network and identification of lncRNA biomarkers for predicting endometrial receptivity. Int J Biol Sci. 2018;14:1361–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Xu H, Zhou M, Cao Y, Zhang D, Han M, Gao X, et al. Genome-wide analysis of long noncoding RNAs, microRNAs, and mRNAs forming a competing endogenous RNA network in repeated implantation failure. Gene. 2019;720:144056.

    Article  CAS  PubMed  Google Scholar 

  24. Bastu E, Demiral I, Gunel T, Ulgen E, Gumusoglu E, Hosseini MK, et al. Potential Marker Pathways in the Endometrium That May Cause Recurrent Implantation Failure. Reprod Sci. 2019;26:879–90.

    Article  CAS  PubMed  Google Scholar 

  25. Pathare ADS, Zaveri K, Hinduja I. Downregulation of genes related to immune and inflammatory response in IVF implantation failure cases under controlled ovarian stimulation. Am J Reprod Immunol. 2017;78:e12679.

  26. Guo F, Si C, Zhou M, Wang J, Zhang D, Leung PCK, et al. Decreased PECAM1-mediated TGF-β1 expression in the mid-secretory endometrium in women with recurrent implantation failure. Hum Reprod. 2018;33:832–43.

    Article  CAS  PubMed  Google Scholar 

  27. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Botía JA, Vandrovcova J, Forabosco P, Guelfi S, D’Sa K, Hardy J, et al. An additional k-means clustering step improves the biological features of WGCNA gene co-expression networks. BMC Syst Biol. 2017;11:47.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.

    Article  PubMed  CAS  Google Scholar 

  31. Bao Z, Yang Z, Huang Z, Zhou Y, Cui Q, Dong D. LncRNADisease 2.0: an updated database of long non-coding RNA-associated diseases. Nucleic Acids Res. 2019;47:D1034-d7.

    Article  CAS  Google Scholar 

  32. Huang HY, Lin YC, Li J, Huang KY, Shrestha S, Hong HC, et al. miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database. Nucleic Acids Res. 2020;48:D148-d54.

    Google Scholar 

  33. Wang X. miRDB: a microRNA target prediction and functional annotation database with a wiki interface. Rna. 2008;14:1012–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005.

  35. Cheadle C, Vawter MP, Freed WJ, Becker KG. Analysis of microarray data using Z score transformation. J Mol Diagn. 2003;5:73–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Carson DD, Bagchi I, Dey SK, Enders AC, Fazleabas AT, Lessey BA, et al. Embryo implantation. Dev Biol. 2000;223:217–37.

    Article  CAS  PubMed  Google Scholar 

  37. Bazer FW, Spencer TE, Johnson GA, Burghardt RC. Uterine receptivity to implantation of blastocysts in mammals. Front Biosci (Schol Ed). 2011;3:745–67.

    Article  Google Scholar 

  38. Lim W, Bae H, Bazer FW, Song G. Fibroblast growth factor 2 induces proliferation and distribution of G(2) /M phase of bovine endometrial cells involving activation of PI3K/AKT and MAPK cell signaling and prevention of effects of ER stress. J Cell Physiol. 2018;233:3295–305.

    Article  CAS  PubMed  Google Scholar 

  39. Lim W, Bae H, Bazer FW, Song G. Ephrin A1 promotes proliferation of bovine endometrial cells with abundant expression of proliferating cell nuclear antigen and cyclin D1 changing the cell population at each stage of the cell cycle. J Cell Physiol. 2019;234:4864–73.

    Article  CAS  PubMed  Google Scholar 

  40. Jung YW, Kim JO, Rah H, Kim JH, Kim YR, Lee Y, et al. Genetic variants of vascular endothelial growth factor are associated with recurrent implantation failure in Korean women. Reprod Biomed Online. 2016;32:190–6.

    Article  CAS  PubMed  Google Scholar 

  41. Shim SH, Kim JO, Jeon YJ, An HJ, Lee HA, Kim JH, et al. Association between vascular endothelial growth factor promoter polymorphisms and the risk of recurrent implantation failure. Exp Ther Med. 2018;15:2109–19.

    CAS  PubMed  Google Scholar 

  42. Ariel I, Weinstein D, Voutilainen R, Schneider T, Lustig-Yariv O, de Groot N, et al. Genomic imprinting and the endometrial cycle. The expression of the imprinted gene H19 in the human female reproductive organs. Diagn Mol Pathol. 1997;6:17–25.

    Article  CAS  PubMed  Google Scholar 

  43. Korucuoglu U, Biri AA, Konac E, Alp E, Onen IH, Ilhan MN, et al. Expression of the imprinted IGF2 and H19 genes in the endometrium of cases with unexplained infertility. Eur J Obstet Gynecol Reprod Biol. 2010;149:77–81.

    Article  CAS  PubMed  Google Scholar 

  44. Zheng HY, Tang Y, Niu J, Li P, Ye DS, Chen X, et al. Aberrant DNA methylation of imprinted loci in human spontaneous abortions after assisted reproduction techniques and natural conception. Hum Reprod. 2013;28:265–73.

    Article  CAS  PubMed  Google Scholar 

  45. Ghazal S, McKinnon B, Zhou J, Mueller M, Men Y, Yang L, et al. H19 lncRNA alters stromal cell growth via IGF signaling in the endometrium of women with endometriosis. EMBO Mol Med. 2015;7:996–1003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Zeng H, Fan X, Liu N. Expression of H19 imprinted gene in patients with repeated implantation failure during the window of implantation. Arch Gynecol Obstet. 2017;296:835–9.

    Article  CAS  PubMed  Google Scholar 

  47. He D, Zeng H, Chen J, Xiao L, Zhao Y, Liu N. H19 regulates trophoblastic spheroid adhesion by competitively binding to let-7. Reproduction. 2019;157:423–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Lou T, Ke K, Zhang L, Miao C, Liu Y. LncRNA PART1 facilitates the malignant progression of colorectal cancer via miR-150-5p/LRG1 axis. J Cell Biochem. 2020;121:4271–81.

  49. Geng YB, Xu C, Wang Y, Zhang LW. Long non-coding RNA SNHG11 promotes cell proliferation, invasion and migration in glioma by targeting miR-154-5p. Eur Rev Med Pharmacol Sci. 2020;24:4901–8.

    PubMed  Google Scholar 

  50. Fan H, Yuan J, Li X, Ma Y, Wang X, Xu B, et al. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression. Biomed Pharmacother. 2020;125:109987.

    Article  CAS  PubMed  Google Scholar 

  51. Xu J, Meng Q, Li X, Yang H, Xu J, Gao N, et al. Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p. Cancer Res. 2019;79:4882–95.

    Article  CAS  PubMed  Google Scholar 

  52. Zeng F, Wang Q, Wang S, Liang S, Huang W, Guo Y, et al. Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression. Oncogene. 2020;39:293–307.

    Article  CAS  PubMed  Google Scholar 

  53. Solary E, Bernard OA, Tefferi A, Fuks F, Vainchenker W. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia. 2014;28:485–96.

    Article  CAS  PubMed  Google Scholar 

  54. Wu X, Zhang Y. TET-mediated active. DNA demethylation: mechanism, function and beyond. Nat Rev Genet. 2017;18:517–34.

    Article  CAS  PubMed  Google Scholar 

  55. Xue Q, Lin Z, Cheng YH, Huang CC, Marsh E, Yin P, et al. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod. 2007;77:681–7.

    Article  CAS  PubMed  Google Scholar 

  56. Izawa M, Taniguchi F, Uegaki T, Takai E, Iwabe T, Terakawa N, et al. Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues. Fertil Steril. 2011;95:33–9.

    Article  CAS  PubMed  Google Scholar 

  57. Xue Q, Lin Z, Yin P, Milad MP, Cheng YH, Confino E, et al. Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5’ CpG island in endometriosis. J Clin Endocrinol Metab. 2007;92:3261–7.

    Article  CAS  PubMed  Google Scholar 

  58. Laws MJ, Taylor RN, Sidell N, DeMayo FJ, Lydon JP, Gutstein DE, et al. Gap junction communication between uterine stromal cells plays a critical role in pregnancy-associated neovascularization and embryo survival. Development. 2008;135:2659–68.

    Article  CAS  PubMed  Google Scholar 

  59. Yu J, Berga SL, Zou W, Sun HY, Johnston-MacAnanny E, Yalcinkaya T, et al. Gap junction blockade induces apoptosis in human endometrial stromal cells. Mol Reprod Dev. 2014;81:666–75.

    Article  CAS  PubMed  Google Scholar 

  60. Yu J, Wu J, Bagchi IC, Bagchi MK, Sidell N, Taylor RN. Disruption of gap junctions reduces biomarkers of decidualization and angiogenesis and increases inflammatory mediators in human endometrial stromal cell cultures. Mol Cell Endocrinol. 2011;344:25–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004;68:320–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Frigo DE, Basu A, Nierth-Simpson EN, Weldon CB, Dugan CM, Elliott S, et al. p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1. Mol Endocrinol. 2006;20:971–83.

    Article  CAS  PubMed  Google Scholar 

  63. Thie M, Harrach-Ruprecht B, Sauer H, Fuchs P, Albers A, Denker HW. Cell adhesion to the apical pole of epithelium: a function of cell polarity. Eur J Cell Biol. 1995;66:180–91.

    CAS  PubMed  Google Scholar 

  64. Whitby S, Salamonsen LA, Evans J. The Endometrial Polarity Paradox: Differential Regulation of Polarity Within Secretory-Phase Human Endometrium. Endocrinology. 2018;159:506–18.

    Article  CAS  PubMed  Google Scholar 

  65. Chubanov V, Gudermann T. TRPM6. Handb Exp Pharmacol. 2014;222:503–20.

    Article  CAS  PubMed  Google Scholar 

  66. De Clercq K, Held K, Van Bree R, Meuleman C, Peeraer K, Tomassetti C, et al. Functional expression of transient receptor potential channels in human endometrial stromal cells during the luteal phase of the menstrual cycle. Hum Reprod. 2015;30:1421–36.

    Article  PubMed  CAS  Google Scholar 

  67. De Clercq K, Van den Eynde C, Hennes A, Van Bree R, Voets T, Vriens J. The functional expression of transient receptor potential channels in the mouse endometrium. Hum Reprod. 2017;32:615–30.

    PubMed  Google Scholar 

Download references


Not applicable.


This study was funded by the National Natural Science Foundation of China (81960288, 81901551) and Shanghai Municipal Health Commission (20144y0101).

Author information

Authors and Affiliations



JH, NS and QW were responsible for the study conception and design. JH, NS and JZ performed the data collection, bioinformatic analyses and manuscript drafting. JH and QC conducted the sample collection and experimental validation. LX, LT and JT contributed to the interpretation and discussion of results. JZ and QW supervised the project administration. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Jing Zhu or Qiongfang Wu.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Institutional Review Board of the First Affiliated Hospital of Wenzhou Medical University (No. 2019-07). Written informed consents were obtained from all participants.

Consent for publication

Not applicable.

Comepting interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Figure S1.

Differential expression of seven hub lncRNAs in GSE111974 dataset. (A) C1orf229. (B) H19. (C) PART1. (D) SCARNA9. (E) SNHG11. (F) LINC00173. (G) MIR17HG. RIF, recurrent implantation failure.

Additional file 2: Figure S2.

Differential expression of seven hub lncRNAs in validation dataset GSE71835. (A) C1orf229. (B) H19. (C) PART1. (D) SCARNA9. (E) SNHG11. (F) LINC00173. (G) MIR17HG. RIF, recurrent implantation failure.

Additional file 3: Table S1.

List of primers used for qRT-PCR.

Additional file 4: Table S2.

Predicted lncRNA-miRNA and mRNA-miRNA pairs for WGCNA modules. WGCNA, weighted gene co‐expression network analysis.

Additional file 5: Table S3.

Predicted lncRNA-miRNA and mRNA-miRNA pairs for the seven hub lncRNA-related ceRNA networks. ceRNA, competing endogenous RNA.

Additional file 6: Table S4.

Topological characteristics of 23 genes overlapped in WGCNA and ceRNA networks. WGCNA, weighted gene co‐expression network analysis; ceRNA, competing endogenous RNA.

Additional file 7: Table S5.

Demographic characteristics of recruited controls and RIF patients. RIF, recurrent implantation failure.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, J., Song, N., Xia, L. et al. Construction of lncRNA-related competing endogenous RNA network and identification of hub genes in recurrent implantation failure. Reprod Biol Endocrinol 19, 108 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: